Page 1 | Search Results | Blood | American Society of Hematology

1-11 of 11

Sort by

Sort Order Select

Journal Articles

Relapse of HHV8-positive multicentric Castleman disease following rituximab-based therapy in HIV-positive patients

Alessia Dalla Pria, David Pinato, Jennifer Roe, Kikeri Naresh, Mark Nelson, Mark Bower

Blood (2017) 129 (15): 2143–2147.

https://doi.org/10.1182/blood-2016-10-747477

Published: 2017

Journal Articles

Plasma HHV8 DNA predicts relapse in individuals with HIV-associated multicentric Castleman disease

Justin Stebbing, Caroline Adams, Adam Sanitt, Salvinia Mletzko, Mark Nelson, Brian Gazzard, Tom Newsom-Davis, Mark Bower

Blood (2011) 118 (2): 271–275.

https://doi.org/10.1182/blood-2011-02-335620

Published: 2011

Journal Articles

Cytokine changes during rituximab therapy in HIV-associated multicentric Castleman disease

Mark Bower, Ophelia Veraitch, Richard Szydlo, Peter Charles, Peter Kelleher, Brian Gazzard, Mark Nelson, Justin Stebbing

Blood (2009) 113 (19): 4521–4524.

https://doi.org/10.1182/blood-2008-12-197053

Published: 2009

Journal Articles

Immunologic recovery in survivors following chemotherapy for AIDS-related non-Hodgkin lymphoma

Mark Bower, Justin Stebbing, Mark Tuthill, Victoria Campbell, Johnathan Krell, Paul Holmes, Andrew Ozzard, Mark Nelson, Brian Gazzard, Tom Powles

Blood (2008) 111 (8): 3986–3990.

https://doi.org/10.1182/blood-2007-10-115659

Published: 2008

Journal Articles

Rituximab as retreatment for rituximab pretreated HIV-associated multicentric Castleman disease

Tom Powles, Justin Stebbing, Silvia Montoto, Mark Nelson, Brian Gazzard, Chloe Orkin, Andy Webb, Mark Bower

Blood (2007) 110 (12): 4132–4133.

https://doi.org/10.1182/blood-2007-08-106187

Published: 2007

Journal Articles

Prion Clearance Capacity Is Improved by Modification of a Filtration Step in the Gamunex® (IGIV) Manufacturing Process.

Michael Mink, Randal Hartwell, Patricia Bauman, Michael Burdick, Michele Kislan, Mark Nelson, Renea’ Oquendo, Dominique Pifat, Kang Cai

Blood (2006) 108 (11): 3860.

https://doi.org/10.1182/blood.V108.11.3860.3860

Published: 2006

Journal Articles

The management of meningeal lymphoma in patients with HIV in the era of HAART: intrathecal depot cytarabine is effective and safe

Danish Mazhar, Justin Stebbing, Rachel Lewis, Mark Nelson, Brian G. Gazzard, Mark Bower

Blood (2006) 107 (8): 3412–3414.

https://doi.org/10.1182/blood-2005-08-3119

Published: 2006

Journal Articles

Protease inhibitors potentiate chemotherapy-induced neutropenia

Mark Bower, Neil McCall-Peat, Natalie Ryan, Liz Davies, Anne Marie Young, Srirupa Gupta, Mark Nelson, Brian Gazzard, Justin Stebbing

Blood (2004) 104 (9): 2943–2946.

https://doi.org/10.1182/blood-2004-05-1747

Published: 2004

Journal Articles

Hepatitis B reactivation during combination chemotherapy for AIDS-related lymphoma is uncommon and does not adversely affect outcome

Justin Stebbing, Mark Atkins, Mark Nelson, Shefali Rajpopat, Tom Newsom-Davis, Brian Gazzard, Mark Bower

Blood (2004) 103 (6): 2431–2432.

https://doi.org/10.1182/blood-2003-12-4222

Published: 2004

Journal Articles

Antibody-targeted MHC complex–directed expansion of HIV-1– and KSHV-specific CD8 + lymphocytes: a new approach to therapeutic vaccination

Justin Stebbing, Brian Gazzard, Steve Patterson, Mark Bower, Dhayaneethie Perumal, Mark Nelson, Andrew McMichael, Graham Ogg, Agamemnon Epenetos, Frances Gotch, Philip Savage

Blood (2004) 103 (5): 1791–1795.

https://doi.org/10.1182/blood-2003-09-3023

Published: 2004

Journal Articles

The heat-shock protein receptor CD91 is up-regulated in monocytes of HIV-1–infected “true” long-term nonprogressors

Justin Stebbing, Brian Gazzard, Louise Kim, Simon Portsmouth, Adrian Wildfire, Ian Teo, Mark Nelson, Mark Bower, Frances Gotch, Sunil Shaunak, Pramod Srivastava, Steve Patterson

Blood (2003) 101 (10): 4000–4004.

https://doi.org/10.1182/blood-2002-11-3353

Published: 2003

NARROW

Relapse of HHV8-positive multicentric Castleman disease following rituximab-based therapy in HIV-positive patients

Plasma HHV8 DNA predicts relapse in individuals with HIV-associated multicentric Castleman disease

Cytokine changes during rituximab therapy in HIV-associated multicentric Castleman disease

Immunologic recovery in survivors following chemotherapy for AIDS-related non-Hodgkin lymphoma

Rituximab as retreatment for rituximab pretreated HIV-associated multicentric Castleman disease

Prion Clearance Capacity Is Improved by Modification of a Filtration Step in the Gamunex® (IGIV) Manufacturing Process.

The management of meningeal lymphoma in patients with HIV in the era of HAART: intrathecal depot cytarabine is effective and safe

Protease inhibitors potentiate chemotherapy-induced neutropenia

Hepatitis B reactivation during combination chemotherapy for AIDS-related lymphoma is uncommon and does not adversely affect outcome

Antibody-targeted MHC complex–directed expansion of HIV-1– and KSHV-specific CD8 + lymphocytes: a new approach to therapeutic vaccination

The heat-shock protein receptor CD91 is up-regulated in monocytes of HIV-1–infected “true” long-term nonprogressors

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only